Skip to main content

Series C Pharmaceutical Companies

Explore 50 pharmaceutical startups that raised series c funding. Access verified founder contact information and fundraising data.

Total Companies
50
Total Funding
$2.0B
Avg Funding
$78.2M
Cities
22

Export 50 Series C Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.

Sep 2021
Series C

Founder Contacts

30,000+ verified contacts

Surry Hills, Australia
$6.9M
raised

HealthMatch connects patients with revolutionary drugs and cures.

Sep 2022
Series C

Founder Contacts

30,000+ verified contacts

San Diego, United States
$60.1M
raised

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Aug 2025
Series C

Founder Contacts

30,000+ verified contacts

Tokyo, Japan
$7.3M
raised

Molcure is a high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics

Aug 2021
Series C

Founder Contacts

30,000+ verified contacts

Philadelphia, United States
$7.0M
raised

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

Jul 2022
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Aurora, United States
$40.0M
raised

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Jun 2022
Series C

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$20.0M
raised

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Jun 2024
Series C

Founder Contacts

30,000+ verified contacts

Atlanta, United States
$27.0M
raised

Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.

Jun 2022
Series C

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$160.5M
raised

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Apr 2024
Series C

Founder Contacts

30,000+ verified contacts

San Carlos, United States
$115.0M
raised

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Apr 2025
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Natick, United States
$182.0M
raised

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Mar 2024
Series C

Founder Contacts

30,000+ verified contacts

Jersey City, United States
$65.0M
raised

The Manufacturing AI Company building intelligent systems that empower teams to automate workflows they never thought possible

Mar 2023
Series C

Founder Contacts

30,000+ verified contacts

Emeryville, United States
$167.0M
raised

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

Mar 2022
Series C

Founder Contacts

30,000+ verified contacts

Minato, Japan
$20.4M
raised

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Mar 2022
Series C

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$100.0M
raised

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

Feb 2026
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Copenhagen, Denmark
$157.0M
raised

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Oct 2025
Series C

Founder Contacts

30,000+ verified contacts

Munich, Germany
$400.6M
raised

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Oct 2025
Series C

Founder Contacts

30,000+ verified contacts

San Diego, United States
$5.4M
raised

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Sep 2025
Series C

Founder Contacts

30,000+ verified contacts

Richmond, United States
$37.0M
raised

Phlow supplies affordable, quality, essential medicines through U.S.-based advanced manufacturing processes.

Jul 2025
Series C

Founder Contacts

30,000+ verified contacts

Melbourne, Australia
$25.7M
raised

PolyActiva develops products that enable drug release from medical devices.

May 2025
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$30.0M
raised

Arine uses AI to optimize medication therapy, improving patient outcomes and reducing healthcare costs for payers and providers.

May 2025
Series C

Founder Contacts

30,000+ verified contacts

Seongnam, South Korea
$13.6M
raised

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Dec 2024
Series C

Founder Contacts

30,000+ verified contacts

Valencia, United States
$115.0M
raised

Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.

Oct 2024
Series C

Founder Contacts

30,000+ verified contacts

Schlieren, Switzerland
$11.0M
raised

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Sep 2024
Series C

Founder Contacts

30,000+ verified contacts

San Mateo, United States
$182.0M
raised

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

May 2024
Series C

Founder Contacts

30,000+ verified contacts

Showing 1 to 25 of 50 companies

Ready to Connect with Series C Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 50 series c pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked